Need2Know Headlines

WeGovy Restrictions to Continue Into 2024

Elsewhere, Danish drug maker, Nova Nordic said yesterday that its popular obesity drug we go will remain in limited supply until 2024. The company cited unprecedented demand for the drug. It's going to continue to restrict supplies on starter doses of the weight loss drug here in the US for several months longer than previously thought. Well, the company said it was prioritizing patients who have already started taking the drug shares. It does we go be shares the same key ingredient as the approved for type two diabetes.